TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT07251933 updates: 1. completion date: 2026-05-29 → 2026-06-30 2. primary completion date: 2026-05-29 → 2026-06-30
Clinical trial NCT07251933 updates: 1. completion date: 2026-05-29 → 2026-06-30 2. primary completion date: 2026-05-29 → 2026-06-30
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical